People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,415.50GBp
12:07pm EDT
Price Change (% chg)

3.50p (+0.25%)
Prev Close
1,412.00p
Open
1,412.50p
Day's High
1,425.50p
Day's Low
1,402.50p
Volume
10,137,866
Avg. Vol
9,650,142
52-wk High
1,709.00p
52-wk Low
1,296.50p

Search Stocks

Podolsky, Daniel 

Brief Biography

Dr. Daniel K. Podolsky is Non-Executive Independent Director of GlaxoSmithKline PLC., since 1 July 2006. He is a world-renowned researcher who has advanced knowledge of underlying mechanisms of disease and new therapies for gastrointestinal disorders. He was formerly Mallinckrodt Professor of Medicine and Chief of Gastroenterology at Massachusetts General Hospital and Harvard Medical School, and previously served as the Chief Academic Officer of Partners Healthcare System. Daniel’s current responsibilities in leading a large academic medical centre give him relevant insight into healthcare delivery. Daniel brings scientific expertise to the Board and the Audit & Risk Committee’s deliberations. He is President of the University of Texas Southwestern Medical Center and holds the Philip O’Bryan Montgomery, Jr., M.D. Distinguished Presidential Chair in Academic Administration, and the Doris and Bryan Wildenthal Distinguished Chair in Medical Science. He is a member of the Institute of Medicine of the US National Academy of Sciences, member of the Board of the Southwestern Medical Foundation and is a Director of Antibe Therapeutics, Inc. He is also a member of the National Academies of Sciences Board on Army Science and Technology.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Christopher Gent

734,000

Andrew Witty

7,207,000

Simon Dingemans

3,292,000

Moncef Slaoui

8,414,000

Deirdre Connelly

--

Roger Connor

--
As Of 30 Dec 2013
Search Stocks